Business Context and Reporting Period
Company: enVVeno Medical Corporation (NVNO)
Filing Type: Form 8-K (Current Report)
Date of Report: November 17, 2025
Reporting Period: Single event date (November 17, 2025)
This filing reports a corporate governance amendment approved by the Board of Directors regarding the Company's Amended and Restated Bylaws.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a bylaw amendment and does not contain financial statements or performance data.
Material Changes
- Bylaw Amendment: The Board approved an amendment to Section 1.5 of the Amended and Restated Bylaws.
- Quorum Requirement: The amendment modifies the quorum requirement for stockholder meetings. The new standard requires the presence in person or by proxy of holders of thirty-three and one-third percent (33 1/3%) in voting power of outstanding shares entitled to vote.
- Effective Date: The amendment became effective immediately upon Board approval on November 17, 2025.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items. The document is limited to the procedural update of corporate bylaws.
Investor Verification Checklist
- Verify the full text of the Amended and Restated Bylaws (Exhibit 3.1) to confirm the exact wording of the quorum change.
- Confirm the impact of the 33 1/3% quorum threshold on the Company's ability to conduct business at future stockholder meetings.
- Review recent 10-K or 10-Q filings for the most current financial position, as this 8-K contains no financial data.